If your gastroenterologist and your prescriber are discussing semaglutide for body weight rather than for glycemic control, the product under discussion is Wegovy, whose labeled purposes include reducing excess body weight and maintaining weight reduction long term in adults with obesity or with overweight plus at least one weight-related comorbid condition
Muscle Loss Factor GLP-1 medications can cause muscle loss along with fat loss, making the skin appear even looser due to the lack of support
I want to walk through it the way I'd explain it to a client sitting in front of me
The dosage is carefully titrated based on how the patient responds over time, ensuring safety and effectiveness
You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a genetic condition that increases the risk of endocrine tumours
Summary: GLP-1 medications slow gut motility and gastric emptying, leading to harder stools and constipation, which can be managed through increased dietary fibre, adequate hydration, regular physical activity, and appropriate laxative use when necessary
